Sara Finley - 23 May 2022 Form 4 Insider Report for TIVITY HEALTH, INC.

Role: Director
Signature: /s/ Joseph Raymond Bilbao by power of attorney for Sara Finley
Issuer symbol: N/A
Transactions as of: 23 May 2022
Net transactions value: -$366,600
Form type: 4
Filing time: 29 Jun 2022, 16:57:39 UTC
Previous filing: 01 Apr 2022
Next filing: 23 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVTY	Common Stock	Gift	$0	-27,681	-71%	$0.000000	11,280	23 May 2022	Direct
transaction	TVTY	Common Stock	Disposed to Issuer	$366,600	-11,280	-100%	$32.50	0	28 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sara Finley is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Includes 2,760 deferred stock units. Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.

Content

Includes 2,760 deferred stock units. Pursuant to the Agreement and Plan of Merger, dated as of April 5, 2022 (the "Merger Agreement"), by and among Tivity Health OpCo Parent, Inc. (f/k/a Titan-Atlas Parent, Inc.), a Delaware corporation ("Parent"), Titan-Atlas Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Tivity Health, Inc. (the "Company"), each share of common stock, par value $0.001 per share, of the Company ("Company Common Stock") was converted into the right to receive a cash payment (without interest and subject to any applicable taxes) equal to the per share merger consideration of $32.50.